Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 19 | Rodrigues Fernando M.President of BetterHelp | Open-market sale · 10b5-1 plan | SELL | $34K 5,439 sh |
| Sep 3, 2026 traded Sep 2, 2026 |
| 18 | Le Pendeven YvesCFO | Open-market sale · 10b5-1 plan | SELL | $222K 34.1K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 17 | Sousa Mauad BrunoDirector | Open-market sale | SELL | $113K 4,075 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 16 | Fego Paul JSVP, Global Operations | Open-market sale · 10b5-1 plan | SELL | $10K 100 sh | Sep 3, 2026 traded Sep 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $4.96M 15.2K sh | Sep 3, 2026 traded Sep 2, 2026 |
| 15 | Guarini KathrynDirector | Open-market sale · 10b5-1 plan | SELL | $340K 400 sh | Sep 3, 2026 traded Sep 2, 2026 |
| 14 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $746K 17.4K sh | Sep 3, 2026 traded Sep 2, 2026 |
| 14 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $275K 6,348 sh | Sep 3, 2026 traded Sep 2, 2026 |
| 14 | Radhakrishnan SrikanthChief Science & Techn. Officer | Open-market sale | SELL | $13K 5,863 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 14 | Radhakrishnan SrikanthChief Science & Techn. Officer | Open-market sale | SELL | $8,177 3,618 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 14 | Radhakrishnan SrikanthChief Science & Techn. Officer | Open-market sale | SELL | $5,973 2,643 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 14 | Sousa Mauad BrunoDirector | Open-market sale | SELL | $54.02 2 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 14 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $821K 19.3K sh | Sep 3, 2026 traded Sep 3, 2026 |
| 14 | Radhakrishnan SrikanthChief Science & Techn. Officer | Open-market sale | SELL | $4,793 2,121 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 13 | Le Pendeven YvesCFO | Open-market sale · 10b5-1 plan | SELL | $48K 6,862 sh | Sep 3, 2026 traded Aug 28, 2026 |
| 13 | Enguent Jean-PierreVice President, R&DSS | Open-market sale · 10b5-1 plan | SELL | $36K 15.0K sh | Sep 3, 2026 traded Sep 3, 2026 |
| 12 | Randhawa SimratEVP, Head of R&D | Open-market sale · 10b5-1 plan | SELL | $767K 7,215 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 11 | Barrett CherieSVP, Chief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $421K 3,985 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 10 | Colburn Richard Edward IIIChief Product & Tech Officer | Open-market sale · 10b5-1 plan | SELL | $89K 1,090 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 10 | Hawkins Matthew J.Director, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $2.14M 82.5K sh | Sep 3, 2026 traded Sep 2, 2026 |
| 10 | Colburn Richard Edward IIIChief Product & Tech Officer | Open-market sale · 10b5-1 plan | SELL | $109K 1,344 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $320K 1,000 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $449K 1,400 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $965K 22.8K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 8 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $37K 858 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 8 | Randhawa SimratEVP, Head of R&D | Open-market sale · 10b5-1 plan | SELL | $273K 2,600 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Viljoen NataschaDirector, President & CEO | Open-market sale · 10b5-1 plan | SELL | $477K 3,882 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Colburn Richard Edward IIIChief Product & Tech Officer | Open-market sale · 10b5-1 plan | SELL | $40K 479 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 7 | Le Pendeven YvesCFO | Open-market sale · 10b5-1 plan | SELL | $12K 1,833 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $193K 600 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $59K 1,368 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 3 | Roth James MChief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $392 94 sh | Sep 3, 2026 traded Sep 2, 2026 |
| 3 | McGrane AshleyGeneral Counsel and Corp Sec | Open-market sale · 10b5-1 plan | SELL | $142 34 sh | Sep 3, 2026 traded Sep 2, 2026 |
| 1 | Arora TarunChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $73K 954 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 42 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale | SELL | $1.55M 40.0K sh | Sep 2, 2026 traded Sep 1, 2026 |
| 42 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale | SELL | $1.55M 40.0K sh | Sep 2, 2026 traded Sep 1, 2026 |
| 42 | Liu ChiDirector, Chief Executive Officer | Open-market sale | SELL | $132K 23.8K sh | Sep 2, 2026 traded Aug 31, 2026 |
| 42 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale | SELL | $1.54M 40.0K sh | Sep 2, 2026 traded Sep 1, 2026 |
| 42 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale | SELL | $1.54M 40.0K sh | Sep 2, 2026 traded Sep 1, 2026 |
| 39 | Zhou ShengleiDirector | Open-market sale | SELL | $36K 6,548 sh | Sep 2, 2026 traded Aug 31, 2026 |